Enveric Biosciences (NASDAQ: ENVB) is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.

Biotechnology

Enveric Bio

Enveric Bio's headquarters in Naples, FL, United States

Joseph Tucker

Kevin Coveney

Peter Facchini

Douglas Lind

Michael D. Webb

Bevin O’Neil

Frank Pasqualone

Maurizio Fava

Stephen M. Stahl

John Krystal

Sheila DeWitt

George Kegler

Michael Liebowitz

The Scientific Advisors Team at Enveric Bio plays a crucial role in guiding the development and testing of cannabinoid-based therapies for cancer treatment side effects. Composed of experts in various scientific disciplines, this team collaborates with researchers, clinicians, and regulatory bodies to ensure that the company's product pipeline is grounded in rigorous scientific evidence and aligns with patient needs. They also provide strategic insights to help shape the company’s research direction and foster innovation in therapeutic solutions.

Scientific Advisors Team

The Leadership Team at Enveric Bio is responsible for setting the strategic vision and guiding the company's mission to develop innovative cannabinoid-based therapies for cancer patients. This team oversees research and development initiatives, fosters collaborations, and ensures alignment with the organization's patient-centric goals while driving growth and securing funding to advance the company's therapeutic pipeline.

Leadership Team

Enveric Bio

Org chart

Board & advisors

Teams

Scientific Advisors Team

Leadership Team

Offices

Enveric Bio

Org chart

Board & advisors

Teams

Scientific Advisors Team

Leadership Team

Offices

Related companies